Skip to content

CODHy 2027’s Program

2027 PROGRAM

May 21 Friday 2027

08:00-10:00Plenary Session 1: Opening Session 
Chair: Wang Weiqing (China)
08:30-08:40 Chairs’ Opening Speech
08:40-09:00 Opening Ceremony

Opening Report
Chairs:  Enrique Caballero (USA); Julio Rosenstock (USA); Stefano Del Prato (Italy)
09:00-09:20 China’s Contribution to Global Diabetes Research (Ning Guang, China)
09:20-09:40 Is Curing Obesity and Diabetes a Realistic Goal? (Itamar Raz, Israel)
09:40-10:00 The Brain as the Manager of Metabolic Disease TBD(Int)
10:00-12:00Plenary Session 2: Keynote Session

Chairs:  Ning Guang (China), Itamar Raz (Israel);
10:00-10:20 Precision Diabetes Care: From Evidence to Personalized Treatment (Enrique Caballero, USA)
10:20-10:40 Cardio-Renal-Metabolic Medicine: A Unified Paradigm (Francesco Cosentino (Sweden)
10:40-11:00 Cardiometabolic Risk Reduction: What the Trials Now Tell Us (Antonio Ceriello, Italy)
11:00-11:20 Key Note Speaker TBD(Int)
11:20-11:40 Keynote Lecture (TBD, China)

11:40-12:00 Hall Turnover and Lunch Box Pickup
 HALL AHALL BHALL C
12:00-14:00Lunch Symposium ALunch Symposium BLunch Symposium C
14:00-15:30Session 1 |
AI & Digital Medicine
 
Chairs: TBD(Int); Kun-Ho Yoon (South Korea)

14:00-14:15 AI and Digital Twins in Diabetes Care，TBD(Int)

14:15-14:30 CGM and Continuous Biological Monitoring，(Tadej Battelino, Slovenia)

14:30-14:45 Digital Health Implementation in Asia，(Kun-Ho Yoon, South Korea)

14:45-15:00 The Chinese AI Ecosystem in Diabetes， (TBD (China))

15:00-15:15 Real-World Evidence from Digital Platforms，(TBD (China))

15:15-15:30 Q&A and Panel Discussion




Session 2 |
Incretin Biology & Obesity Science

Chairs: TBD ;  TBD

14:00-14:15 Triple Agonists and the Next Generation of Incretins，TBD(Int)

14:15-14:30 Obesity Pharmacotherapy: Real-World Evidence & Guidelines，TBD(Int)

14:30-14:45 Obesity & Metabolic Surgery: Where Do We Stand?，(Francesco Rubino, UK)

14:45-15:00 Incretin-Based Therapy in Chinese Patients，(TBD (China))

15:00-15:15 Weight Management in China: Clinical Experience，(TBD (China))

15:15-15:30 Q&A and Panel Discussion




Session 3 |
Cardio-Renal-Metabolic Medicine

Chairs: Francesco Cosentino (Sweden);
TBD(Int)

14:00-14:15 The Future of Complication Prevention: Heart Failure，(Francesco Cosentino, Sweden)

14:15-14:30 Kidney Protection in Diabetes，(Per-Henrik Groop, Finland)

14:30-14:45 Precision Prevention of Cardiometabolic Disease，(TBD, China)

14:45-15:00 CKM Management in Chinese Patients，(TBD (China))

15:00-15:15 Cardio-Renal Outcomes: China Data，(TBD (China))

15:15-15:30 Q&A and Panel Discussion





15:30-17:00Session 4 | Obesity, Brain & Behavior

Chairs: TBD(Int), TBD(Int)

15:30-15:45 Obesity as a Chronic Metabolic Disease，TBD(Int)

15:45-16:00 Muscle Biology in Metabolic Health，TBD(Int)

16:00-16:15 Self-Control and Obesity: Neurological and Involuntary?，(TBD (China))

16:15-16:30 Stress, Cortisol, Visceral Fat & Mental Health，(TBD (China))

16:30-16:45 Sleep, Obesity and Metabolic Risk ，(TBD )

16:45-17:00 Q&A and Panel Discussion
Session 5 | Liver, Gut & MASLD

Chairs: TBD(Int); Stefano Del Prato (Italy)

15:30-15:45 MASLD: From Mechanisms to Therapy, (Stefano Del Prato, Italy)

15:45-16:00 MASLD in Asian Patients，TBD(Int)

16:00-16:15 The Gut Microbiome in Obesity and Diabetes，(TBD (China))

16:15-16:30 MASLD in Chinese Patients: Clinical Practice，(TBD (China))

16:30-16:45 Precision Nutrition: Evidence-Based or Marketing?，TBD(Int)

16:45-17:00 Q&A and Panel Discussion

Session 6 | Disease Modification: Remission & Cell Therapy

Chairs: TBD(Int); TBD(Int)

15:30-15:45 Beta-Cell Preservation and Disease Modification，TBD(Int)

15:45-16:00 Immunometabolism & Immune Modulation in T1D，TBD(Int)

16:00-16:15 T2D Remission in China: Real Healing or Temporary Repose?，(TBD (China))

16:15-16:30 Cell Therapy: China Progress，(TBD (China))

16:30-16:45 Beta-Cell Biology in Asian Young-Onset Diabetes，(Kun-Ho Yoon, South Korea)

16:45-17:00 Q&A and Panel Discussion
17:00-18:00CODHy Master Class Series
Interactive Learning with World Leaders
Divided into several private rooms, each dedicated to a different topic.

May 22 SATURDAY 2027

 HALL AHALL BHALL C
08:30-10:10Session 7 |
The Future of Diabetes

Chairs: Itamar Raz (Israel); Julio Rosenstock (USA)

08:30-08:50 The Future of Diabetes Care，(Itamar Raz, Israel)

08:50-09:10 Clinical Diabetes: Lessons from Recent Trials，(Julio Rosenstock, USA)

09:10-09:30 Effects ofGLP-1RA and Tirzepatide discontinuation，(Antonio Ceriello, Italy)

09:30-09:50 China’s Contribution to Global Diabetes Research，(TBD (China))

09:50-10:10 Q&A and Panel Discussion




Session 8 |
Precision Medicine & Longevity

Chairs: Enrique Caballero (USA); Stefano Del Prato (Italy)

08:30-08:50 Precision Medicine: Hype or Reality?，(Enrique Caballero, USA)

08:50-09:10 Cardiometabolic Health and Healthy Longevity，TBD(Int)

09:10-09:30 Precision Medicine in Chinese Populations，TBD (China)

09:30-09:50 Genetics and Personalized Medicine in China，TBD (China)

09:50-10:10 Q&A and Panel Discussion




Session 9 |
Population Health & Real-World Evidence

Chairs: Kamlesh Khunti (UK); TBD(Int)
08:30-08:50 Population Health and Diabetes Prevention,  (Kamlesh Khunti, UK)

08:50-09:10 Real-World Evidence & Guidelines，TBD(Int)

09:10-09:30 Young-Onset Type 2 Diabetes in China, (TBD (China))

09:30-09:50 Real-World Evidence from Chinese Cohorts,(TBD (China))

09:50-10:10 Q&A and Panel Discussion





10:10-11:50Session 10 |
Cardiometabolic Risk

Chairs: Francesco Cosentino (Sweden), TBD(Int)

10:10-10:30 Cardiometabolic Risk: New Frontiers, TBD(Int)

10:30-10:50 Heart Failure Prevention in Diabetes,(Francesco Cosentino, Sweden)

10:50-11:10 Hypertension in Metabolic Disease: China Perspective, (TBD (China))

11:10-11:30 Cardiometabolic Risk in Chinese Patients, (TBD (China))

11:30-11:50 Q&A and Panel Discussion



Session 11 |
Young Scientist & Rising Star Session

Five young scientists present their research — topics to be confirmed

10:10-10:30 Young Scientist Presentation 1 — to be confirmed (TBD)

10:30-10:50 Young Scientist Presentation 2 — to be confirmed (TBD)

10:50-11:10 Young Scientist Presentation 3 — to be confirmed (TBD)

11:10-11:30 Young Scientist Presentation 4 — to be confirmed (TBD)

11:30-11:50 Young Scientist Presentation 5 — to be confirmed (TBD)


Session 12 |
Diabetic Foot & Limb Preservation

Chairs:  TBD(Int); TBD (China)

10:10-10:30 The Future of Diabetic Foot Care, TBD(Int)

10:30-10:50 Limb Preservation and Podiatric Surgery, TBD(Int)

10:50-11:10 The Diabetic Foot in China: Current Situation, (TBD (China))

11:10-11:30 Diabetic Foot Management: Chinese Clinical Experience, (TBD (China))

11:30-11:50 Q&A and Panel Discussion







11:50-12:00

12:00-14:00
Lunch box Pickup

Lunch Symposium D		Lunch box Pickup

Lunch Symposium E		Lunch box Pickup

Lunch Symposium F
14:00-15:30Session 13 |
Glycemic Variability & Technology

Chairs: Chairs: (Antonio Ceriello, Italy)
; TBD(Int)
14:00-14:15 Glycemic Variability: Why It Matters,  (Antonio Ceriello, Italy)

14:15-14:30 CGM in the Era of AI, (Int)

14:30-14:45 Technology-Enabled Care in Asia,(TBD, China)

14:45-15:00 Digital Therapeutics in China, (TBD, China)

15:00-15:15 CGM Implementation in Chinese Practice, (TBD, China)

15:15-15:30 Q&A and Panel Discussion





Session 14 |
Muscle Biology & Frontiers in Biology

Chairs: TBD(Int); TBD(Int)

14:00-14:15 Muscle as a Metabolic Organ, (TBD, China)

14:15-14:30 Inter-organ Metabolic Communication, (TBD, Int)

14:30-14:45 Frontiers in Metabolic Biology, (TBD, Int)

14:45-15:00 Muscle Biology Research in China, (TBD (China))

15:00-15:15 Single-Cell Insights: China Studies, (TBD (China))

15:15-15:30 Q&A and Panel Discussion



  
Session 15 |
Asia-Pacific Perspectives

Chairs: TBD(Int); TBD(Int)

14:00-14:15 Diabetes in Asian Populations, TBD(Int)

14:15-14:30 Obesity in Asia, TBD(Int)

14:30-14:45 Diabetes Care in Southeast Asia, TBD(Int)

14:45-15:00 Diabetes in Chinese Populations, (TBD (China))

15:00-15:15 China’s Contribution to Asian Diabetes Research, (TBD (China))

15:15-15:30 Q&A and Panel Discussion





15:30-17:00Session 16 |
Clinical Diabetes & Mechanisms

Chairs: Julio Rosenstock (USA); Stefano Del Prato (Italy)

15:30-15:45 Clinical Diabetes: State of the Art, (Julio Rosenstock, USA)

15:45-16:00 Mechanisms & Translational Science, (Stefano Del Prato, Italy)

16:00-16:15 Reducing Therapeutic Inertia, (TBD, China)

16:15-16:30 Clinical Diabetes Management in China, (TBD, China)

16:30-16:45 Translational Research from China, (TBD, China)

16:45-17:00 Q&A and Panel Discussion		   Session 17 |
Immunometabolism & Guideline Implementation

Chairs: TBD(Int); Kamlesh Khunti (UK)

15:30-15:45 Immunometabolism in Diabetes, TBD(Int)

15:45-16:00 Guideline Implementation Across Populations, (Kamlesh Khunti, UK)

16:00-16:15 Bridging Guidelines and Practice, (TBD, China)

16:15-16:30 Chinese Diabetes Guidelines: Implementation, (TBD, China)

16:30-16:45 Immunometabolism Research in China, (TBD, China)

16:45-17:00 Q&A and Panel Discussion		MMC Session

15:30-18:00

Reserved for MMC — no program scheduled.

Room available until 18:00.